Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06063213 · ClinicalTrials.gov registry record
Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation
A clinical trial of Transplant Complication, sponsored by University of Florida.
- Active
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06063213: Active study of Transplant Complication, sponsored by University of Florida.
NCT06063213 is a study of Transplant Complication that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06063213, a study of Transplant Complication, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop a prospective quantitative liver allograft monitoring protocol and retrospectively validate the use of Phenotypic personalized medicine (PPM) in immunosuppression dosing in liver transplant recipients.
Primary Outcome
Patients will be followed for six months after transplantation according to standard of care. Episodes of biopsy proven rejection will be counted.
Conditions Studied
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-12-15 |
| Est. Completion | 2026-10-15 |
What the registry record for NCT06063213 still lists
NCT06063213 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 1 condition, with Transplant Complication appearing as the primary indexed condition, and to 0 interventions.
NCT06063213 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06063213 about?
NCT06063213 is a clinical study titled "Using Transcriptional Assessment of Immune Response to Assess Immunosuppression After Liver Transplantation". To develop a prospective quantitative liver allograft monitoring protocol and retrospectively validate the use of Phenotypic personalized medicine (PPM) in immunosuppression dosing in liver transplant recipients.
What is the current status of trial NCT06063213?
This trial is currently active not recruiting. The enrollment target is 40 participants. The study started on 2023-12-15. Estimated completion is 2026-10-15.
What conditions does trial NCT06063213 study?
This clinical trial studies the following conditions: Transplant Complication.
Who is sponsoring clinical trial NCT06063213?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06063213 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transplant Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI